On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will be subject to negotiation under the Inflation Reduction Act (IRA). The medications were chosen based on criteria outlined in the IRA. The law requires CMS to prioritize drugs with the […]
This article was written in coordination with the Center for Medicare Advocacy and the Legal Action Center. As our country continues to face a mental health crisis and overdose epidemic, increasing access to mental health and substance use disorder treatment must be a significant priority for policymakers, patients, providers, and […]
In advance of this week’s one-year anniversary of the Inflation Reduction Act (IRA), the Biden-Harris administration released a set of fact sheets last month highlighting health care cost savings achieved under the IRA and the Affordable Care Act (ACA) in each of the fifty states and the District of Columbia. […]
This week marked the one-year anniversary of the signing of the Inflation Reduction Act (IRA), landmark legislation that allows Medicare to negotiate drug prices for the first time and penalize manufacturers who raise prices faster than inflation, among other changes. The Congressional Budget Office estimates $100 billion in savings for […]
As we near the first anniversary of the Inflation Reduction Act (IRA), recent public polling by KFF shows that many adults cannot afford their medications as prescribed, and a large majority say there is not enough regulation of drug pricing and that they do not trust pharmaceutical companies to set […]
Medicare Rights recently released Medicare Advantage 101, a series of explainers and videos covering the rise and potential downfalls of the Medicare Advantage (MA) program. The series delves into MA history and the current system of overpayment that is burdening Medicare and taxpayers. One factor driving increased MA payment is […]
As more features of the Inflation Reduction Act (IRA) are implemented, more people with Medicare are seeing the benefits of the law. According to new research, this includes better access to care. There have been thousands more insulin prescriptions filled for Medicare beneficiaries since the IRA’s insulin cost-sharing limits went […]
Many of Medicare’s 65 million enrollees can struggle to pay for coverage and care. The program’s benefit design and lack of financial protections leave beneficiaries exposed to high premiums and cost-sharing and on the hook for the full cost of services that Medicare does not cover, such as comprehensive dental, […]
